CSP exam test Questions with Answers 100% Solved

CSP exam test Questions with Answers
100% Solved
PDCAcalculationA-
AAnswerAPDCA=A(#AofAuniqueAdaysAwithAsupplyA/AnumberAofAdaysAinAaAperiod)AxA100



WhichAmedicationAisAaAJakAinhibitor?

a.AHumiraA(adalimumab)

b.AOrenciaA(abatacept)

c.AActemraA(toclizumab)

d.AXeljanzA(tofacitinib)A-AAnswerAd.AXeljanzA(tofacitinib)



WhichAmedicationAcanAelevateAcholesterol?

a.AActemraA(toclizumab)

b.AEnbrelA(etanercept)

c.ASimponiA(golimumab)

d.AKineretA(anakinra)A-AAnswerAa.AActemraA(toclizumab)



WhichAshinglesAvaccineAisAsafeAtoAadministerAwithATNFAinhibitors?

a.AAdacel

b.AZostavax

c.AShingrix

d.AVarivaxA-AAnswerAc.AShingrix



MostAbiologicsAincreaseAtheAriskAofAinfections,AwhichAofAtheAfollowingAalsoAincreasesAtheAri
skAof

neutropenia?

a.ARituxinA(rituximab)

b.ATaltzA(ixekizumab)

c.ARemicadeA(infliximab)

d.ACimziaA(certolizumabApegol)A-AAnswerAb.ATaltzA(ixekizumab)

, WhichApsoriasisAmedicationAdoesAnotArequireAscreeningAforAtuberculosis?

a.AStelaraA(ustekinumab)

b.AOtezlaA(apremilast)

c.ACocentyxA(seculinumab)

d.AHumiraA(adalimumab)A-AAnswerAb.AOtezlaA(apremilast)



WhatAisAtheAstandardAstartingAdoseAforATaltzA(ixekizumab)AwhenAusedAtoAtreatApsoriaticAart
hritis?

a.A160mgAsubcutaneouslyAonce,AfollowedAbyA80mgAsubcutaneouslyAatAweeksA2,A4,A6,A8,A10

andA12;AthenA80mgAsubcutaneouslyAeveryA4Aweeks

b.A160mgAsubcutaneouslyAonce,AfollowedAbyA80mgAsubcutaneouslyAeveryA4Aweeks

c.A160mgAsubcutaneouslyAonce,AfollowedAbyA80mgAsubcutaneouslyAeveryAweekAforA4Aweeks
,

thenA80mgAeveryA4Aweeks

d.A160mgAsubcutaneouslyAonce,AfollowedAbyA80mgAsubcutaneouslyAeveryAotherAweekA-
AAnswerAb.A160mgAsubcutaneouslyAonce,AfollowedAbyA80mgAsubcutaneouslyAeveryA4Aweeks



AA45Ay/o,A200lbApatientAisAstrugglingAwithAsevereAdermatitisAandAtheAproviderAwantsAtoAp
otentially

startAaAbiologic.AWhichAmedicationAwouldAyouArecommend?

a.AProtopicA(tacrolimus)

b.AHumiraA(adalimumab)

c.AStelaraA(ustekinumab)

d.ADupixentA(dupilumab)A-AAnswerAd.ADupixentA(dupilumab)



AA56Ay/o,A140lbApatientAwithApsoriasisAwillAbeAstartingAStelaraA(ustekinumab),AbutAtheAprov
ider

wantsAtoAverifyAtheAdosingAofAtheAmedication.AWhatAstartingAdoseAwouldAyouArecommend?

a.AInjectA45AmgAsubcutaneouslyAatAweeksA0AandA4,AfollowedAbyA45AmgAeveryA12Aweeks

b.AInjectA90AmgAsubcutaneouslyAatAweeksA0AandA4,AfollowedAbyA90AmgAeveryA12Aweeks

c.AInfuseA260AmgAIVAoverAatAleastA1AhourAasAaAsingleAdose,AfollowedA8AweeksAlaterAwithA
90Amg

subcutaneouslyAeveryA8Aweeks